Trademark Overview
On Thursday, July 20, 2023, a trademark application was filed for GLPG with the United States Patent and Trademark Office. The USPTO has given the GLPG trademark a serial number of 98094108. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 1, 2024. This trademark is owned by Galapagos NV. The GLPG trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
pharmaceutical substances and preparations for human use, namely, for the treatment of inflammatory diseases, autoinflammation diseases, autoimmune diseases, proliferative diseases, cancer, skin diseases, cardiovascular diseases, anti-infectives, hepatitis B virus, osteoarthritis, rheumatoid arthritis, atopic dermatitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma; biopharmaceutical substances and preparations for human use, namely, for the treatment of inflammatory diseases, autoinflammation diseases, autoimmune diseases, proliferative diseases, cancer, skin diseases, cardiovascular diseases, anti-infectives, hepatitis B virus, osteoarthritis, rheumatoid arthritis, atopic dermatitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma
medical services; medical and pharmaceutical advisory and consultancy services; gene bank services
medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, chimeric antigen receptor T-cell therapy, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate those databases via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; gene bank ...
